SciQuest has received two awards. Triangle Business Journal picked the company for its best places to work. And PricewaterhouseCoopers selected the firm for its Fast 50 list. “Our outstanding workforce is at the heart of every success and recognition that SciQuest receives,” said Stephen Wiehe, SciQuest president and CEO. “Our employees’ dedication to providing our customers with leading-edge procurement solutions and round-the-clock support stems from the collaborative culture and gratifying environment that also makes SciQuest a great place to work.” Here’s the release.

Encorium Group appointed Wall Street veteran Shahab Fatheazam to its board of directors. Fatheazam is currently head of the U.S. health care practice of GCA Savvian, a leading international investment banking advisory firm. “We are very pleased to welcome Shahab to our Board,” commented David Ginsberg, president and CEO of Encorium. “With over 30 years of experience in capital markets, mergers and acquisitions and other advisory activities for a broad array of clients in the health care industry, we believe his advice and counsel will be invaluable as we navigate through the challenges and opportunities ahead.”

The University of Cincinnati (UC) now offers a master’s degree program providing comprehensive training in clinical research for practicing physicians. The program was approved by the UC board of trustees in September and is currently under review by the Ohio Board of Regents. Here’s the release.

Harlan, a contract research organization (CRO), launched a new company name and marketing slogan, “helping you do research better.”  Effective immediately, Harlan Sprague Dawley, Teklad, RCC, and SafePharm Laboratories will be known as Harlan Laboratories. Said Steve Sullivan, CEO: “From proven research models and services to world-class contract research, Harlan Laboratories offers researchers the experience, quality and consistency that is essential to their success.”

CMIC, a Japanese CRO, has joined Medidata’s program for contract research organizations. “This strategic partnership with Medidata came as a result of the growing demand for Medidata Rave among our customers in Japan and the Asia-Pacific region,” said Makoto Sato, corporate officer at CMIC. “We are confident that its ease of use and multi-language functionality will meet our customers’ needs for EDC at all phases of clinical trials and help them to successfully bring new medical solutions to market. One of the reasons for selecting Rave is that it furthers the goal of achieving completely electronic clinical trials.”

PHT Corporation is providing its electronic patient diary to headache experts at Clinvest Clinical Research, which is measuring cognitive deficits during migraine attacks. This is the first time cognitive processing time has been tested in a major migraine research study. “We didn’t have to reinvent the wheel for this program,” said Dennis Reeves, VP at Clinvest. “We partnered with PHT to integrate our highly sensitive cognitive processing test system into the LogPad. The test results are seamlessly transferred into the PHT database and we can access it for the data analysis. Because the LogPad automatically uploads the data to the database, the Clinvest analysis team can remotely review, download analyze and report on the cognitive data in real time.” Here’s the release.

Have a news release? Send it to